Buy the pullback in this major pharma stock: Bernstein
Bernstein has reiterated its Outperform rating on a major global pharmaceutical firm, urging investors to "lean into" the drugmaker's pipeline ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
